Pharmaceuticals

Global Sotorasib Tablets Market Report 2026–2035: Key Forecasts and Growth Areas

February 18, 2026February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the sotorasib tablets market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Sotorasib Tablets Market in 2030?

The sotorasib tablets market has seen rapid expansion in recent years. It is anticipated to increase from $1.92 billion in 2025 to $2.16 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.3%. The market’s past growth is attributable to the increasing diagnosis of non-small cell lung cancer, advancements in kras mutation research, regulatory approvals for targeted oncology drugs, expansion of molecular diagnostic capabilities, and growth in oncology clinical trials.

The sotorasib tablets market is projected to experience rapid expansion over the coming years, with its size anticipated to reach $3.4 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.0%. This growth during the forecast period can be attributed to several factors including the increasing development of next-generation kras inhibitors, rising combination therapy approaches, the expansion of targeted treatments into additional cancer indications, the growing use of real-world evidence studies, and the increasing adoption of oncology precision medicine. Major trends expected in the forecast period encompass the increasing adoption of kras g12c inhibitor therapies, a rising focus on targeted lung cancer treatments, the growing use of oral oncology medications, the expansion of companion diagnostic testing, and enhanced monitoring of resistance mechanisms.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28336&type=smp

What Drivers Are Influencing Production Trends In The Sotorasib Tablets Market?

The increasing incidence of cancer is anticipated to fuel the expansion of the sotorasib tablets market in the coming years. This condition encompasses various illnesses characterized by the unchecked proliferation of abnormal cells, their invasion into tissues, and potential dissemination throughout the body. The growing number of cancer cases is attributed to an aging demographic, given that advanced age constitutes the primary risk factor for developing most forms of cancer, with a predominant number of diagnoses occurring in those aged above 65. Sotorasib tablets operate by precisely and permanently targeting the KRAS G12C mutation, effectively deactivating the altered protein to inhibit uncontrolled cellular proliferation in individuals with advanced solid tumors, especially non-small cell lung cancer. For example, data from the World Health Organization, a global health body based in Switzerland, indicated in February 2024 that forecasts suggest more than 35 million new cancer diagnoses by 2050, marking a 77% rise from the approximately 20 million cases recorded in 2022. Consequently, the increasing prevalence of cancer is propelling the expansion of the sotorasib tablets market.

Which Segments Are Gaining Traction In The Sotorasib Tablets Market?

The sotorasib tablets market covered in this report is segmented –

1) By Dosage Form: 40 Milligrams (Mg) Tablets, 120 Milligrams (Mg) Tablets, 240 Milligrams (Mg) Tablets, Other Dosage Forms

2) By Patient Demographics: Adolescents, Adult, Senior Adults

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By Application: Non-Small Cell Lung Cancer, Colorectal Cancer, Other Applications

5) By End-User: Hospitals, Oncology Centers, Clinics, Other End-Users

What Upcoming Trends Are Likely To Define The Future Path Of The Sotorasib Tablets Market?

Leading firms operating in the sotorasib tablets market are concentrating on developing innovative therapies, such as combination treatments, to enhance efficacy and overcome resistance. Combination therapies involve the concurrent use of two or more drugs to target cancer through multiple mechanisms simultaneously, thereby increasing treatment effectiveness, mitigating or delaying drug resistance, reducing the likelihood of cancer recurrence, and improving overall patient outcomes and quality of life. For instance, in January 2025, Amgen Inc., a US-based biotechnology company, secured U.S. Food and Drug Administration (FDA) approval for sotorasib in conjunction with panitumumab for treating adult patients with KRAS G12C–mutated metastatic colorectal cancer (mCRC) who had previously received standard chemotherapy. This approval was granted based on the outcomes of the Phase 3 CodeBreaK 300 study, which demonstrated that the combination more than doubled progression-free survival compared to the investigator’s choice of standard-of-care therapy, providing a significant new treatment option for patients facing this difficult-to-treat cancer. Sotorasib is a first-in-class, oral KRAS G12C inhibitor that operates by selectively targeting and locking the mutant KRAS protein in its inactive state, consequently blocking cancer cell growth and the signaling pathways driven by this mutation.

Who Are The Primary Competitors In The Global Sotorasib Tablets Market?

Major companies operating in the sotorasib tablets market are Amgen Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/sotorasib-tablets-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Sotorasib Tablets Market?

North America was the largest region in the sotorasib tablets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sotorasib tablets market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Sotorasib Tablets Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28336&type=smp

Browse Through More Reports Similar to the Global Sotorasib Tablets Market 2026, By The Business Research Company

Tablets Market Report 2026

https://www.thebusinessresearchcompany.com/report/tablets-global-market-report

Ashwagandha Extract Market Report 2026

https://www.thebusinessresearchcompany.com/report/ashwagandha-extract-global-market-report

Cholinergic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/cholinergic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795